Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation

Frontiers in Pharmacology(2020)10.3389/fphar.2020.00038Source: DataRank Database

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation is a research paper published in Frontiers in Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Sundararaman Swaminathan ORCID,Matthew D. Griffin ORCID

Live enrichment

PubMed:32116714 PMC:PMC7016012 OpenAlex:https://openalex.org/W3004505405

NIDDK NIH HHS

Grant: R01 DK103043

European Commission

Grant: 634086

Novel Stromal Cell Therapy for Diabetic Kidney Disease

National Institutes of Health

Grant: 5R01DK103043-03

Targeting Cellular Iron Dynamics for Protection in Kidney Injury

European Commission

Grant: 602470

Adverse Immune Signatures and their Prevention in Corneal Transplantation

Science Foundation Ireland

Grant: 13/RC/2073

CÚRAM - Centre for Research in Medical Devices

goldLicense: cc-by

journalhttps://doi.org/10.3389/fphar.2020.00038

publisherhttps://doi.org/10.3389/fphar.2020.00038

publisherhttps://www.frontiersin.org/article/10.3389/fphar.2020.00038/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32116714

repositoryhttp://hdl.handle.net/10379/16398

Fields of Study

Renal Diseases and GlomerulopathiesChronic Kidney Disease and DiabetesDialysis and Renal Disease Management03 medical and health sciences0302 clinical medicine

Keywords

MedicineInflammationPharmacologyInternal medicineSepsisDiabetic nephropathyInterstitial fibrosisChronic Kidney DiseaseAcute Kidney InjuryTherapeutic TargetsBiologic AgentsCHRONIC KIDNEY-DISEASEINHIBITIONRM1-950Regenerative Medicine InstitutePharmacology (medical)Therapeutics. PharmacologyBURDEN

Sustainable Development Goals

SDG 3: 3. Good health